Page 412 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 412

390   PART IV    Specific Malignancies in the Small Animal Patient


                                                                  Some authors advocate prophylactic irradiation of cyto-
                                                               logically negative regional LNs (prophylactic nodal irradiation
                                                                                Owing to the generally low risk of postsurgi-
                                                               [PNI]).
                                                                     114,123,124,163
  VetBooks.ir                                                  cal metastasis in low- to intermediate-grade tumors, PNI is prob-
                                                               ably unwarranted in this group of patients, and at least one study
                                                               has demonstrated no advantage in terms of disease-free or overall
                                                               survival when PNI is employed 159 ; however, in MCTs at high risk
                                                               for metastasis, PNI may provide improvement in outcome over
                                                               local site irradiation only. 114,163
                                                                  For cases in which planned curative excisional surgery is unsuc-
                                                               cessful and histologic margins are incomplete, further local ther-
                                                               apy is generally warranted. If possible, a second excision of the
                                                               surgical scar with additional wide margins should be performed
                                                               (Fig. 21.6); however, some evidence suggests that marginal, “stag-
                                                               ing” reexcision of dirty surgical scars may be associated with an
                                                               acceptable  likelihood  of  achieving  tumor-free  margins. 78,162,164
                                                               Alternatively, adjuvant RT can be used in cases in which reexcision
                                                               is not an option. Not all MCTs with surgically incomplete mar-
                                                               gins will recur; in some studies only 10% to 30% of MCTs with
                                                               histologically confirmed incomplete margins did so. 92,162,165  One
                                                               study suggests that measurement of proliferation indices (Ki67 and
                                                               PCNA) via IHC may be useful in predicting likelihood of recur-
                                                                                                                92
                                                               rence after incomplete resection of intermediate-grade MCTs.
                                                               Although recurrence rates vary by study, several studies have dem-
                                                               onstrated increased local recurrence rates and/or decreased overall
                                                               STs in dogs with incompletely resected MCTs. 28,78,80,120  Fig. 21.7
                                                               summarizes the treatment recommendations for clinical stage 0
                                                               and I, histologically low- or intermediate-grade MCTs.
                                                                  Alternative local therapies for MCTs have been reported and
                                                               include hyperthermia in combination with RT, 166  intralesional
                                                               brachytherapy, 167  photodynamic therapy, 168,169  intralesional cor-
         •  Fig. 21.6  Reexcision of a mast cell tumor from the skin of a golden   ticosteroids, 170,171  cryotherapy, and electrochemotherapy. 172–175
         retriever. The first surgery resulted in incomplete surgical margins. Three-   Although some have advocated the use of intralesional deionized
         cm margins are taken around and deep to the previous incision and the   water at the site of an incompletely excised MCT, clinical data
         entire sample is again submitted for margin analysis by the pathologist.  indicate that this approach is not effective at preventing local

                           Anatomic site amenable to wide surgical excision?


                                                            Options:
                                                            Ideal: Cytoreductive surgery and adjuvant radiation therapy
                                               No
                                                            Alternative choices:
                                   Yes                      Cytoreduction followed by medical therapy
                                                            Cytoreduction followed by active surveillance
                                                            Radiation therapy alone (possible surgery to follow)
                                                            Medical therapy alone (possible surgery to follow)

                            Excise with wide surgical margins.
                            Assess margins and confirm grade.

                                                                  Options:
                                                        No        Reexcision with wide margins
                                                                  “Staging” reexcision
                              Complete surgical margins?          Adjuvant rediation therapy
                                                                  Adjuvant medical therapy
                                                                  Active surveillance
                                    Yes


                            Routine follow-up:

                            1, 3, 6, 9, 12, 15, 18 months
                            q 6 months thereafter
                            Physical exam and lymph node exam
                          • Fig. 21.7  Suggested treatment approach for clinical stage 0 and 1 canine mast cell tumors of low or
                          intermediate grade.
   407   408   409   410   411   412   413   414   415   416   417